STEVE ANTOLINE Insider Trading for February 2014
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for STEVE ANTOLINE.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Overview of insider trading of STEVE ANTOLINE for February 2014.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 13 2014 | PRGB | Protea Biosciences ... | ANTOLINE STEVE | Director | Option Exercise | P | 1.10 | 250,000 | 275,000 | 6,160,847 | |
Feb 13 2014 | PRGB | Protea Biosciences ... | ANTOLINE STEVE | Director | Option Exercise | P | 1.10 | 250,000 | 275,000 | 6,160,847 | |
Feb 13 2014 | PRGB | Protea Biosciences ... | ANTOLINE STEVE | Director | Option Exercise | P | 0.75 | 152,750 | 114,563 | 5,910,847 | |
Feb 13 2014 | PRGB | Protea Biosciences ... | ANTOLINE STEVE | Director | Option Exercise | P | 0.75 | 152,750 | 114,563 | 5,910,847 | |
Feb 13 2014 | PRGB | Protea Biosciences ... | ANTOLINE STEVE | Director | Option Exercise | P | 0.50 | 305,500 | 152,750 | 5,758,097 | |
Feb 13 2014 | PRGB | Protea Biosciences ... | ANTOLINE STEVE | Director | Option Exercise | P | 0.50 | 305,500 | 152,750 | 5,758,097 | |
Feb 13 2014 | PRGB | Protea Biosciences ... | ANTOLINE STEVE | Director | Option Exercise | C | 0.50 | 305,500 | 152,750 | 5,452,597 | |
Feb 13 2014 | PRGB | Protea Biosciences ... | ANTOLINE STEVE | Director | Option Exercise | C | 0.50 | 305,500 | 152,750 | 5,452,597 | |
Feb 13 2014 | PRGB | Protea Biosciences ... | ANTOLINE STEVE | Director | Option Exercise | C | 0.50 | 251,667 | 125,834 | 5,752,597 | |
Feb 13 2014 | PRGB | Protea Biosciences ... | ANTOLINE STEVE | Director | Option Exercise | C | 0.50 | 251,667 | 125,834 | 5,752,597 | |
Feb 13 2014 | PRGB | Protea Biosciences ... | ANTOLINE STEVE | Director | Option Exercise | P | 0.75 | 125,833 | 94,375 | 6,002,597 | |
Feb 13 2014 | PRGB | Protea Biosciences ... | ANTOLINE STEVE | Director | Option Exercise | P | 0.75 | 125,833 | 94,375 | 6,002,597 | |
Feb 13 2014 | PRGB | Protea Biosciences ... | ANTOLINE STEVE | Director | Option Exercise | P | 0.50 | 251,667 | 125,834 | 5,876,764 | |
Feb 13 2014 | PRGB | Protea Biosciences ... | ANTOLINE STEVE | Director | Option Exercise | P | 0.50 | 251,667 | 125,834 | 5,876,764 | |
Feb 13 2014 | PRGB | Protea Biosciences ... | ANTOLINE STEVE | Director | Option Exercise | P | 0.50 | 300,000 | 150,000 | 5,625,097 | |
Feb 13 2014 | PRGB | Protea Biosciences ... | ANTOLINE STEVE | Director | Option Exercise | P | 0.50 | 300,000 | 150,000 | 5,625,097 | |
Feb 13 2014 | PRGB | Protea Biosciences ... | ANTOLINE STEVE | Director | Option Exercise | P | 0.50 | 250,000 | 125,000 | 5,325,097 | |
Feb 13 2014 | PRGB | Protea Biosciences ... | ANTOLINE STEVE | Director | Option Exercise | P | 0.50 | 250,000 | 125,000 | 5,325,097 | |
Feb 13 2014 | PRGB | Protea Biosciences ... | ANTOLINE STEVE | Director | Option Exercise | P | 1.10 | 93,750 | 103,125 | 5,075,097 | |
Feb 13 2014 | PRGB | Protea Biosciences ... | ANTOLINE STEVE | Director | Option Exercise | P | 1.10 | 93,750 | 103,125 | 5,075,097 | |
Feb 13 2014 | PRGB | Protea Biosciences ... | ANTOLINE STEVE | Director | Option Exercise | P | 1.10 | 1,000,000 | 1,100,000 | 4,981,347 | |
Feb 13 2014 | PRGB | Protea Biosciences ... | ANTOLINE STEVE | Director | Option Exercise | P | 1.10 | 1,000,000 | 1,100,000 | 4,981,347 | |
Feb 13 2014 | PRGB | Protea Biosciences ... | ANTOLINE STEVE | Director | Option Exercise | C | 0.50 | 1,990,684 | 995,342 | 3,981,347 | |
Feb 13 2014 | PRGB | Protea Biosciences ... | ANTOLINE STEVE | Director | Option Exercise | C | 0.50 | 1,990,684 | 995,342 | 3,981,347 | |
Feb 13 2014 | PRGB | Protea Biosciences ... | ANTOLINE STEVE | Director | Option Exercise | P | 1.10 | 1,493,013 | 1,642,314 | 5,731,347 | |
Feb 13 2014 | PRGB | Protea Biosciences ... | ANTOLINE STEVE | Director | Option Exercise | P | 1.10 | 1,493,013 | 1,642,314 | 5,731,347 | |
Feb 13 2014 | PRGB | Protea Biosciences ... | ANTOLINE STEVE | Director | Option Exercise | P | 1.10 | 150,000 | 165,000 | 4,238,334 | |
Feb 13 2014 | PRGB | Protea Biosciences ... | ANTOLINE STEVE | Director | Option Exercise | P | 1.10 | 150,000 | 165,000 | 4,238,334 | |
Feb 13 2014 | PRGB | Protea Biosciences ... | ANTOLINE STEVE | Director | Option Exercise | P | 1.10 | 1,100,000 | 1,210,000 | 4,088,334 | |
Feb 13 2014 | PRGB | Protea Biosciences ... | ANTOLINE STEVE | Director | Option Exercise | P | 1.10 | 1,100,000 | 1,210,000 | 4,088,334 | |
Feb 13 2014 | PRGB | Protea Biosciences ... | ANTOLINE STEVE | Director | Option Exercise | P | 0.50 | 300,000 | 150,000 | 2,988,334 | |
Feb 13 2014 | PRGB | Protea Biosciences ... | ANTOLINE STEVE | Director | Option Exercise | P | 0.50 | 300,000 | 150,000 | 2,988,334 | |
Feb 13 2014 | PRGB | Protea Biosciences ... | ANTOLINE STEVE | Director | Option Exercise | P | 0.50 | 250,000 | 125,000 | 2,688,334 | |
Feb 13 2014 | PRGB | Protea Biosciences ... | ANTOLINE STEVE | Director | Option Exercise | P | 0.50 | 250,000 | 125,000 | 2,688,334 | |
Feb 13 2014 | PRGB | Protea Biosciences ... | ANTOLINE STEVE | Director | Option Exercise | P | 0.50 | 200,000 | 100,000 | 2,438,334 | |
Feb 13 2014 | PRGB | Protea Biosciences ... | ANTOLINE STEVE | Director | Option Exercise | P | 0.50 | 200,000 | 100,000 | 2,438,334 | |
Feb 13 2014 | PRGB | Protea Biosciences ... | ANTOLINE STEVE | Director | Option Exercise | P | 2.25 | 25,000 | 56,250 | 2,238,334 | |
Feb 13 2014 | PRGB | Protea Biosciences ... | ANTOLINE STEVE | Director | Option Exercise | P | 2.25 | 25,000 | 56,250 | 2,238,334 | |
Feb 13 2014 | PRGB | Protea Biosciences ... | ANTOLINE STEVE | Director | Option Exercise | P | 0.50 | 1,000,000 | 500,000 | 2,213,334 | |
Feb 13 2014 | PRGB | Protea Biosciences ... | ANTOLINE STEVE | Director | Option Exercise | P | 0.50 | 1,000,000 | 500,000 | 2,213,334 | |
Feb 13 2014 | PRGB | Protea Biosciences ... | ANTOLINE STEVE | Director | Option Exercise | P | 2.00 | 6,667 | 13,334 | 1,213,334 | |
Feb 13 2014 | PRGB | Protea Biosciences ... | ANTOLINE STEVE | Director | Option Exercise | P | 2.00 | 6,667 | 13,334 | 1,213,334 | |
Feb 13 2014 | PRGB | Protea Biosciences ... | ANTOLINE STEVE | Director | Option Exercise | P | 2.00 | 36,667 | 73,334 | 1,206,667 | |
Feb 13 2014 | PRGB | Protea Biosciences ... | ANTOLINE STEVE | Director | Option Exercise | P | 2.00 | 36,667 | 73,334 | 1,206,667 | |
Feb 13 2014 | PRGB | Protea Biosciences ... | ANTOLINE STEVE | Director | Option Exercise | P | 1.50 | 100,000 | 150,000 | 1,170,000 | |
Feb 13 2014 | PRGB | Protea Biosciences ... | ANTOLINE STEVE | Director | Buy | P | 0.50 | 305,500 | 152,750 | 4,565,232 | 4.3 M to 4.6 M (+7.17 %) |
Feb 13 2014 | PRGB | Protea Biosciences ... | ANTOLINE STEVE | Director | Buy | P | 0.50 | 305,500 | 152,750 | 4,565,232 | 4.3 M to 4.6 M (+7.17 %) |
Feb 13 2014 | PRGB | Protea Biosciences ... | ANTOLINE STEVE | Director | Buy | P | 0.50 | 251,667 | 125,834 | 4,259,732 | 4 M to 4.3 M (+6.28 %) |
Feb 13 2014 | PRGB | Protea Biosciences ... | ANTOLINE STEVE | Director | Buy | P | 0.50 | 251,667 | 125,834 | 4,259,732 | 4 M to 4.3 M (+6.28 %) |
Feb 13 2014 | PRGB | Protea Biosciences ... | ANTOLINE STEVE | Director | Buy | P | 0.50 | 1,990,684 | 995,342 | 4,008,065 | 2 M to 4 M (+98.68 %) |
Feb 13 2014 | PRGB | Protea Biosciences ... | ANTOLINE STEVE | Director | Buy | P | 0.50 | 1,990,684 | 995,342 | 4,008,065 | 2 M to 4 M (+98.68 %) |
Feb 13 2014 | PRGB | Protea Biosciences ... | ANTOLINE STEVE | Director | Buy | P | 0.50 | 200,000 | 100,000 | 2,017,381 | 1.8 M to 2 M (+11.00 %) |
Feb 13 2014 | PRGB | Protea Biosciences ... | ANTOLINE STEVE | Director | Buy | P | 0.50 | 200,000 | 100,000 | 2,017,381 | 1.8 M to 2 M (+11.00 %) |
Feb 13 2014 | PRGB | Protea Biosciences ... | ANTOLINE STEVE | Director | Buy | P | 2.00 | 50,000 | 100,000 | 1,817,381 | 1.8 M to 1.8 M (+2.83 %) |
Feb 13 2014 | PRGB | Protea Biosciences ... | ANTOLINE STEVE | Director | Buy | P | 2.00 | 50,000 | 100,000 | 1,817,381 | 1.8 M to 1.8 M (+2.83 %) |
Feb 13 2014 | PRGB | Protea Biosciences ... | ANTOLINE STEVE | Director | Buy | P | 1.50 | 13,333 | 20,000 | 1,767,381 | 1.8 M to 1.8 M (+0.76 %) |
Feb 13 2014 | PRGB | Protea Biosciences ... | ANTOLINE STEVE | Director | Buy | P | 1.50 | 13,333 | 20,000 | 1,767,381 | 1.8 M to 1.8 M (+0.76 %) |
Feb 13 2014 | PRGB | Protea Biosciences ... | ANTOLINE STEVE | Director | Buy | P | 1.50 | 73,333 | 110,000 | 1,754,048 | 1.7 M to 1.8 M (+4.36 %) |
Feb 13 2014 | PRGB | Protea Biosciences ... | ANTOLINE STEVE | Director | Buy | P | 1.50 | 73,333 | 110,000 | 1,754,048 | 1.7 M to 1.8 M (+4.36 %) |